Massive SARS-CoV-2 RT-PCR Testing on Rural Communities in Manabi Province (Ecuador) Reveals Severe COVID-19 Outbreaks

ABSTRACT Rural communities from Latin America are particularly susceptible to develop serious outbreaks of infectious diseases. Inadequate diagnosis and poor health infrastructure jeopardize proper contact tracing and other actions to reduce the impact of COVID-19 in the region. We herein describe the preliminary data of our ongoing fieldwork of massive testing among nonhospitalized rural population in Manabi Province of the coastal region of Ecuador. A total of 1,479 people from six different rural communities were tested for SARS-CoV-2 by RT-qPCR following the CDC protocol; 350 individuals tested positive, resulting in an overall attack rate of 23.7% for SARS-CoV-2 infection. This ultrahigh prevalence must urge to the public health authorities from Ecuador to take immediate actions to counteract this dramatic scenario in Manabi Province and to improve SARS-CoV-2 testing countrywide.

[1]  A. Vélez,et al.  Analytical and clinical comparison of Viasure (CerTest Biotec) and 2019-nCoV CDC (IDT) RT-qPCR kits for SARS-CoV2 diagnosis. , 2020, Virology.

[2]  M. Garcia-Bereguiain,et al.  Poor sensitivity of "AccuPower SARS-CoV-2 real time RT-PCR kit (Bioneer, South Korea)" , 2020, Virology journal.

[3]  M. Garcia-Bereguiain,et al.  Analytical sensitivity and clinical performance of a triplex RT-qPCR assay using CDC N1, N2, and RP targets for SARS-CoV-2 diagnosis , 2020, International Journal of Infectious Diseases.

[4]  A. Vélez,et al.  “One health" inspired SARS-CoV-2 surveillance: The Galapagos Islands experience , 2020, One Health.

[5]  A. Vélez,et al.  "Sample pooling of RNA extracts to speed up SARS-CoV-2 diagnosis using CDC FDA EUA RT-qPCR kit" , 2020, Virus Research.

[6]  R. Lowe,et al.  Epidemiological, socio-demographic and clinical features of the early phase of the COVID-19 epidemic in Ecuador , 2020, medRxiv.

[7]  S. Lindstrom,et al.  US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 , 2020, Emerging infectious diseases.

[8]  A. Vélez,et al.  Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: an example of the need of validation studies. , 2020, medRxiv.

[9]  A. Vélez,et al.  Cotton-Tipped Plastic Swabs for SARS-CoV-2 RT-qPCR Diagnosis to Prevent Supply Shortages , 2020, Frontiers in Cellular and Infection Microbiology.